6-Amino-8-cyclopentyl-2-[5-(3-ethylamino-pyrrolidin-1-yl)-pyridin-2-ylamino]-8H-pyrido[2,3-d]pyrimidin-7-one | 571190-83-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶并嘧啶类
• 英文名称: 6-Amino-8-cyclopentyl-2-[5-(3-ethylamino-pyrrolidin-1-yl)-pyridin-2-ylamino]-8H-pyrido[2,3-d]pyrimidin-7-one
• 英文别名: 6-Amino-8-cyclopentyl-2-[[5-[3-(ethylamino)pyrrolidin-1-yl]pyridin-2-yl]amino]pyrido[2,3-d]pyrimidin-7-one
• CAS: 571190-83-5
• 化学式: C₂₃H₃₀N₈O
• 分子量: 434.544
• InChiKey: MXGRWPKUHJWJOE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  32
• 可旋转键数：
  6
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.48
• 拓扑面积：
  112
• 氢给体数：
  3
• 氢受体数：
  8

文献信息

• 2-(Pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
  申请人：——

  公开号：US20030149001A1

  公开（公告）日：2003-08-07

  The present invention provides substituted 2-aminopyridines useful in treating cell proliferative disorders. The novel compounds of the present invention are potent inhibitors of cyclin-dependent kinases 4 (cdk4). 1

  这项发明提供了用于治疗细胞增殖性疾病的取代2-氨基吡啶。本发明的新化合物是cyclin-dependent激酶4 (cdk4)的有效抑制剂。
• METHODS OF USING CELL-CYCLE INHIBITORS TO MODULATE ONE OR MORE PROPERTIES OF A CELL CULTURE
  申请人：AMGEN INC.

  公开号：US20150353542A1

  公开（公告）日：2015-12-10

  Methods of modulating the properties of a cell culture expressing a protein of interest are provided. In various embodiments the methods relate to the addition of cell cycle inhibitors to growing cell cultures.

  提供了一种调节表达感兴趣蛋白的细胞培养物性质的方法。在各种实施方式中，该方法涉及向生长的细胞培养物中添加细胞周期抑制剂。
• 2-(Pyridin-2-ylamino)-pyrido [2,3-D]pyrimidin-7-ones
  申请人：Barvian Mark

  公开号：US20050137214A1

  公开（公告）日：2005-06-23

  The present invention provides substituted 2-aminopyridines useful in treating cell proliferative disorders. The novel compounds of the present invention are potent inhibitors of cyclin-dependent kinases 4 (cdk4).

  本发明提供了可用于治疗细胞增殖性疾病的取代的2-氨基吡啶。本发明的新型化合物是cyclin-dependent kinases 4 (cdk4)的强效抑制剂。
• 2-(PYRIDIN-2-YLAMINO)-PYRIDO [2,3 D]PYRIMIDIN-7-ONES
  申请人：Barvian Mark

  公开号：US20070179118A1

  公开（公告）日：2007-08-02

  The present invention provides substituted 2-aminopyridines useful in treating cell proliferative disorders. The novel compounds of the present invention are potent inhibitors of cyclin-dependent kinases 4 (cdk4).

  本发明提供了替代2-氨基吡啶，用于治疗细胞增殖性疾病。本发明的新化合物是cyclin-dependent kinases 4 (cdk4)的有效抑制剂。
• CONTACT LENS COMPOSITION, AND CONTACT LENS AND METHOD FOR MANUFACTURING SAME
  申请人：Toray Industries, Inc.

  公开号：EP3627212A1

  公开（公告）日：2020-03-25

  The purpose of the present invention is to provide a contact lens composition that is polymerizable in a mold and that can easily be peeled from a mold, a cured material of the contact lens composition, a contact lens in which the cured material of the contact lens composition is disposed in at least a center part thereof, and a method for manufacturing the contact lens. This contact lens composition for achieving the above purpose has the following composition. Specifically, the contact lens composition contains (a) a polymerizable crosslinking agent having a multi-ring alicyclic hydrocarbon structure and (b) silicone having a radical polymerizable group.

  本发明的目的是提供一种可在模具中聚合且易于从模具中剥离的隐形眼镜组合物、该隐形眼镜组合物的固化材料、将该隐形眼镜组合物的固化材料至少置于其中心部分的隐形眼镜，以及制造该隐形眼镜的方法。这种用于实现上述目的的隐形眼镜组合物具有以下成分。具体来说，该隐形眼镜组合物包含：(a) 具有多环脂环烃结构的可聚合交联剂；(b) 具有可自由基聚合基团的硅氧烷。